1. Home
  2. CDXS vs CTW Comparison

CDXS vs CTW Comparison

Compare CDXS & CTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Codexis Inc.

CDXS

Codexis Inc.

N/A

Current Price

$1.23

Market Cap

141.8M

Sector

Industrials

ML Signal

N/A

CTW

CTW Cayman Class A Ordinary Shares

N/A

Current Price

$1.79

Market Cap

93.6M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
CDXS
CTW
Founded
2002
2013
Country
United States
Japan
Employees
N/A
N/A
Industry
Major Chemicals
EDP Services
Sector
Industrials
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
141.8M
93.6M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
CDXS
CTW
Price
$1.23
$1.79
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.5M
45.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
20.54
N/A
EPS
N/A
N/A
Revenue
$138,590,000.00
N/A
Revenue This Year
$15.64
N/A
Revenue Next Year
$5.23
N/A
P/E Ratio
N/A
$22.41
Revenue Growth
32.30
N/A
52 Week Low
$0.96
$1.10
52 Week High
$3.87
$3.14

Technical Indicators

Market Signals
Indicator
CDXS
CTW
Relative Strength Index (RSI) 49.98 56.21
Support Level $1.17 $1.19
Resistance Level $1.24 $1.77
Average True Range (ATR) 0.11 0.19
MACD 0.04 0.04
Stochastic Oscillator 81.94 66.07

Price Performance

Historical Comparison
CDXS
CTW

About CDXS Codexis Inc.

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.

About CTW CTW Cayman Class A Ordinary Shares

CTW Cayman operates the web-based HTML5 gaming platform G123.jp, offering free-to-play games based on Japanese animations, including Queen's Blade, So I'm a Spider, So What?, and Goblin Slayer. The platform features 29 games, with 11 in pre-registration. The Group provides a platform for game developers to generate revenue and reach an international audience through shared revenue from players' in-game purchases. It operates in Japan, Singapore, Taiwan, and China, excluding Taiwan, with the majority of revenue derived from Japan, and has one reporting segment focused on game distribution and related services.

Share on Social Networks: